Tumoral EHF predicts the efficacy of anti-PD1 therapy in pancreatic ductal adenocarcinoma
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tumoral EHF predicts the efficacy of anti-PD1 therapy in pancreatic ductal adenocarcinoma
Authors
Keywords
-
Journal
JOURNAL OF EXPERIMENTAL MEDICINE
Volume 216, Issue 3, Pages 656-673
Publisher
Rockefeller University Press
Online
2019-02-08
DOI
10.1084/jem.20180749
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Progress and challenges of predictive biomarkers of anti PD-1/PD-L1 immunotherapy: A systematic review
- (2018) Feifei Teng et al. CANCER LETTERS
- Tumor Mutation Burden: Leading Immunotherapy to the Era of Precision Medicine?
- (2018) Conor E. Steuer et al. JOURNAL OF CLINICAL ONCOLOGY
- Combined effect of anti-BAG3 and anti-PD-1 treatment on macrophage infiltrate, CD8 + T cell number and tumour growth in pancreatic cancer
- (2017) Vittoria Iorio et al. GUT
- Overcoming immune evasion in pancreatic cancer: the combination matters
- (2017) Patrick Michl et al. GUT
- Ets homologous factor (EHF) has critical roles in epithelial dysfunction in airway disease
- (2017) Sara L. Fossum et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Treg depletion potentiates checkpoint inhibition in claudin-low breast cancer
- (2017) Nicholas A. Taylor et al. JOURNAL OF CLINICAL INVESTIGATION
- Myeloid-derived suppressor cells—a new therapeutic target to overcome resistance to cancer immunotherapy
- (2017) Jason A. Chesney et al. JOURNAL OF LEUKOCYTE BIOLOGY
- The pancreatic cancer microenvironment: A true double agent
- (2017) Laleh G. Melstrom et al. JOURNAL OF SURGICAL ONCOLOGY
- JASPAR 2018: update of the open-access database of transcription factor binding profiles and its web framework
- (2017) Aziz Khan et al. NUCLEIC ACIDS RESEARCH
- Development of Aggressive Pancreatic Ductal Adenocarcinomas Depends on Granulocyte Colony Stimulating Factor Secretion in Carcinoma Cells
- (2017) Michael W. Pickup et al. Cancer Immunology Research
- A circulating TH2 cytokines profile predicts survival in patients with resectable pancreatic adenocarcinoma
- (2017) Geny Piro et al. OncoImmunology
- Depletion of tumor-associated macrophages switches the epigenetic profile of pancreatic cancer infiltrating T cells and restores their anti-tumor phenotype
- (2017) Simone Borgoni et al. OncoImmunology
- Seed-in-Soil: Pancreatic Cancer Influenced by Tumor Microenvironment
- (2017) Huey-Jen Lin et al. Cancers
- CXCR2 Inhibition Profoundly Suppresses Metastases and Augments Immunotherapy in Pancreatic Ductal Adenocarcinoma
- (2016) Colin W. Steele et al. CANCER CELL
- Myeloid-derived suppressor cells and their role in pancreatic cancer
- (2016) M Pergamo et al. CANCER GENE THERAPY
- T-cell programming in pancreatic adenocarcinoma: a review
- (2016) Y D Seo et al. CANCER GENE THERAPY
- Current progress in immunotherapy for pancreatic cancer
- (2016) Kelly Foley et al. CANCER LETTERS
- ESE3 Inhibits Pancreatic Cancer Metastasis by Upregulating E-Cadherin
- (2016) Tiansuo Zhao et al. CANCER RESEARCH
- TGF Signaling in the Pancreatic Tumor Microenvironment Promotes Fibrosis and Immune Evasion to Facilitate Tumorigenesis
- (2016) D. R. Principe et al. CANCER RESEARCH
- Activation of the Lin28/let-7 Axis by Loss of ESE3/EHF Promotes a Tumorigenic and Stem-like Phenotype in Prostate Cancer
- (2016) D. Albino et al. CANCER RESEARCH
- Suppression of Type I IFN Signaling in Tumors Mediates Resistance to Anti-PD-1 Treatment That Can Be Overcome by Radiotherapy
- (2016) Xiaohong Wang et al. CANCER RESEARCH
- Myeloid-Derived Suppressor Cell Subset Accumulation in Renal Cell Carcinoma Parenchyma Is Associated with Intratumoral Expression of IL1β, IL8, CXCL5, and Mip-1α
- (2016) Yana G. Najjar et al. CLINICAL CANCER RESEARCH
- Myeloid cells are required for PD-1/PD-L1 checkpoint activation and the establishment of an immunosuppressive environment in pancreatic cancer
- (2016) Yaqing Zhang et al. GUT
- MicroRNA-424 impairs ubiquitination to activate STAT3 and promote prostate tumor progression
- (2016) Cecilia Dallavalle et al. JOURNAL OF CLINICAL INVESTIGATION
- PD-1 blockade in mismatch repair deficient non-colorectal gastrointestinal cancers.
- (2016) Dung T. Le et al. JOURNAL OF CLINICAL ONCOLOGY
- Role of immune cells in pancreatic cancer from bench to clinical application
- (2016) Jae Hyuck Chang et al. MEDICINE
- TGF 1-Mediated SMAD3 Enhances PD-1 Expression on Antigen-Specific T Cells in Cancer
- (2016) B. V. Park et al. Cancer Discovery
- The ETS factor ESE3/EHF represses IL-6 preventing STAT3 activation and expansion of the prostate cancer stem-like compartment
- (2016) Domenico Albino et al. Oncotarget
- A Threshold Level of Intratumor CD8 + T-cell PD1 Expression Dictates Therapeutic Response to Anti-PD1
- (2015) Shin Foong Ngiow et al. CANCER RESEARCH
- Classifying Cancers Based on T-cell Infiltration and PD-L1
- (2015) Michele W.L. Teng et al. CANCER RESEARCH
- Systemic Immune Activity Predicts Overall Survival in Treatment-Nai ve Patients with Metastatic Pancreatic Cancer
- (2015) M. R. Farren et al. CLINICAL CANCER RESEARCH
- Phase I Study of Pembrolizumab (MK-3475; Anti-PD-1 Monoclonal Antibody) in Patients with Advanced Solid Tumors
- (2015) A. Patnaik et al. CLINICAL CANCER RESEARCH
- IFN Regulatory Factor 8 Represses GM-CSF Expression in T Cells To Affect Myeloid Cell Lineage Differentiation
- (2015) Amy V. Paschall et al. JOURNAL OF IMMUNOLOGY
- Robust Antitumor Effects of Combined Anti-CD4-Depleting Antibody and Anti-PD-1/PD-L1 Immune Checkpoint Antibody Treatment in Mice
- (2015) S. Ueha et al. Cancer Immunology Research
- The checkpoint inhibitor TIGIT limits antitumor and antiviral CD8+T cell responses
- (2015) Robert J Johnston et al. OncoImmunology
- Targeted depletion of an MDSC subset unmasks pancreatic ductal adenocarcinoma to adaptive immunity
- (2014) Ingunn M Stromnes et al. GUT
- Disruption of CXCR2-Mediated MDSC Tumor Trafficking Enhances Anti-PD1 Efficacy
- (2014) S. L. Highfill et al. Science Translational Medicine
- Role of the immune system in pancreatic cancer progression and immune modulating treatment strategies
- (2013) K. Sideras et al. CANCER TREATMENT REVIEWS
- The immune network in pancreatic cancer development and progression
- (2013) S M Wörmann et al. ONCOGENE
- Silencing the Killers: Paracrine Immune Suppression in Pancreatic Cancer
- (2012) Adrienne D. Cox et al. CANCER CELL
- Tumor-Derived Granulocyte-Macrophage Colony-Stimulating Factor Regulates Myeloid Inflammation and T Cell Immunity in Pancreatic Cancer
- (2012) Lauren J. Bayne et al. CANCER CELL
- ESE3/EHF Controls Epithelial Cell Differentiation and Its Loss Leads to Prostate Tumors with Mesenchymal and Stem-like Features
- (2012) D. Albino et al. CANCER RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now